Printer Friendly

Endo Announces names Matthew J. Maletta as chief legal officer.

M2 PHARMA-April 29, 2015-Endo Announces names Matthew J. Maletta as chief legal officer

(C)2015 M2 COMMUNICATIONS

Pharmaceutical company Endo International (NasdaqGS:ENDP) (TSX:ENL.TO) revealed on Tuesday the addition of Matthew J. Maletta as its executive vice president and chief legal officer with effect from 4 May 2015.

Maletta, who brings to the company nearly two decades of legal experience in the pharmaceutical industry, private law firms, extensive experience in M&A, corporate, securities, finance, commercial and employment law, succeeds the outgoing Caroline B. Manogue.

Most recently, Maletta has served as vice president, associate general counsel and corporate secretary of Allergan as well as served as an advisor to the CEO and board of directors and supervised several large M&A transactions and takeover defense activities.

Previously, Maletta has worked as a corporate counsel and assistant secretary at Allergan, played a key role negotiating its Corporate Integrity Agreement with the Department of Justice as well as served as the lead commercial attorney for the Allergan medical businesses and Interim Head of Human Resources.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Apr 29, 2015
Words:186
Previous Article:Postive Results Published on Actavis, Medicines360 Study on Intrauterine System.
Next Article:IGI Laboratories incurs lower Q1 2015 adjusted net income per fully diluted share of USD0.00.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters